| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.075 | 0.8 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |